Compare OMH & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMH | PLSM |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Singapore | Israel |
| Employees | N/A | 63 |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 23.2M |
| IPO Year | 2022 | N/A |
| Metric | OMH | PLSM |
|---|---|---|
| Price | $0.99 | $3.38 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 20.7K | 1.9K |
| Earning Date | 05-12-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.40 | N/A |
| Revenue Next Year | $23.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.59 | $3.00 |
| 52 Week High | $3.28 | $6.85 |
| Indicator | OMH | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 42.37 |
| Support Level | $0.98 | $3.00 |
| Resistance Level | $1.38 | $3.93 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 42.31 | 13.73 |
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.